Erratum
While compiling this article [1] one of the authors was inadvertently omitted from the author list. This author, The Canadian Critical Care Trials Group (CCCTG), has been included in the corrected author list above.
Acknowledgements
Members of the Canadian Critical Care Trials Group (CCCTG):
Anzeige
Dr Jon Hooper, Tracy McArdle, Shawna Reddie, Dr Peter Wilkes, Denyse Winch, Dr Claudio Martin, Eileen Campbell, Dr Sangeeta Mehta, Maedean Brown, Dr Peter Dodek, Betty Jean Ashley, Dr John Marshall and Orla Smith.
Competing interests
Andrew Seely is Founder and Chief Science Officer of Therapeutic Monitoring Systems (TMS); TMS aims to commercialize patent-protected applications of multiorgan variability monitoring to provide variability-directed clinical decision support at the bedside to improve care for patients at risk for or with existing critical illness. Andrew Seely holds a patent jointly with co-authors Andrea Bravi and André Longtin on composite measures of variability. Geoffrey Green is Product Manager for TMS. John Marshall and Gari Clifford are on the Scientific Advisor Board of TMS. Other authors have no relevant conflict of interest to disclose.